Search Results

Results 1–15 of 15
Sort By: Relevance| Date| Title

1.
December 2016

Members Only


Practice Bulletin Number 203, January 2019

Members Only


Members Only


Members Only


Practice Bulletin Number 202, January 2019

Members Only


Members Only


Committee Opinion Number 565, June 2013

(Replaces No. 420, November 2008) (Reaffirmed 2018)

ABSTRACT: Menopausal hormone therapy should not be used for the primary or secondary prevention of coronary heart disease at the present time. Evidence is insufficient to conclude that long-term estrogen therapy or hormone therapy use improves cardiovascular outcomes. Nevertheless, recent evidence suggests that women in early menopause who are in good cardiovascular health are at low risk of adverse cardiovascular outcomes and should be considered candidates for the use of estrogen therapy or conjugated equine estrogen plus a progestin for relief of menopausal symptoms. There is some evidence...


Committee Opinion Number 698, May 2017

ABSTRACT: Primary ovarian insufficiency describes a spectrum of declining ovarian function and reduced fecundity due to a premature decrease in initial follicle number, an increase in follicle destruction, or poor follicular response to gonadotropins. The sequelae of primary ovarian insufficiency include vasomotor symptoms, urogenital atrophy, osteoporosis and fracture, cardiovascular disease, and increased all-cause mortality. In women with primary ovarian insufficiency, systemic hormone therapy (HT) is an effective approach to treat the symptoms of hypoestrogenism and mitigate long-term hea...


Members Only


10.
December 2016

Members Only


11.
December 2017

Members Only


Practice Bulletin Number 212, May 2019

Members Only


13.
December 2016

Members Only


Members Only


15.
December 2016

Members Only


Advertisement

American College of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188
Mailing Address: PO Box 96920, Washington, DC 20024-9998